K. Ochiai

Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study

K. Kaku, Yusuke Naito, A. Yasui, 2019, Expert opinion on drug safety.

Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study

N. Hayashi, T. Hirase, Tomo-o Okamura, 2020, Diabetes Therapy.

Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance

N. Hayashi, Tomo-o Okamura, Yusuke Naito, 2020, Expert opinion on drug safety.

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study

Michiyasu Suzuki, H. Yokota, M. Yasaka, 2020, Cardiology and Therapy.

Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study

N. Hayashi, Tomo-o Okamura, Fumiko Yamamoto, 2019, Diabetes Therapy.

Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in plasma and urine by use of a chiral cellulose-derivative column.

K. Chiba, T. Ishizaki, H. Echizen, 1990, Clinical chemistry.

Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan

Y. Sugiyama, Y. Kondoh, Y. Inoue, 2023, Advances in Therapy.

Stereoselective disposition and metabolism of disopyramide in pediatric patients.

K. Chiba, T. Ishizaki, H. Echizen, 1991, The Journal of pharmacology and experimental therapeutics.